[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630430":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":41,"collaborators":10,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":68,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Sohag University","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Group I: MASLD patients with acute coronary syndrome (ACS).",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Group II: MASLD patients without acute coronary syndrome",[14],{"name":15,"affiliation":16,"role":17},"Usama Ahmed Arafa, MD","unaffillated","PRINCIPAL_INVESTIGATOR",[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Mariam Adeeb Samy, Resident","CONTACT","01202515622","mariam_adeeb_post@med.sohag.edu.eg",[25],{"facility":26,"status":10,"city":27,"state":28,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Sohag University Hospital","Sohag","Sohag Governorate","Egypt","EG",{"type":32,"coordinates":33},"Point",[34,35],31.69478,26.55695,{"lat":35,"lon":34},[38,39,40],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"name":10,"role":21,"phone":10,"phoneExt":10,"email":23},{"name":20,"role":17,"phone":10,"phoneExt":10,"email":10},{"type":17,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Mariam Adeeb Samy","Resident","100630430","mpv-as-a-predictor-for-acs-in-patients-with-masld-100630430",false,"NCT07487571","MPV as a Predictor for ACS in Patients With MASLD","Mean Platelet Volume as a Predictor for Acute Coronary Syndrome in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease","MPV\u002FACS MASLD","Inclusion Criteria:\n\n* Adult patients aged ≥18 years.\n* Confirmed diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) based on clinical, laboratory, and imaging criteria).\n* Patients diagnosed with acute coronary syndrome (unstable angina, NSTEMI, or STEMI) for Group I.\n* MASLD patients without clinical or electrocardiographic evidence of acute coronary syndrome for Group II.\n* Patients who provide informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Patients with chronic liver diseases other than MASLD (e.g., viral hepatitis, autoimmune hepatitis, alcoholic liver disease).\n* Patients with known hematological disorders affecting platelet count or function.\n* Patients receiving antiplatelet or anticoagulant therapy prior to blood sampling.\n* Patients with active infection, inflammatory diseases, or malignancy.\n* Patients with chronic kidney disease or end-stage renal failure.\n* Pregnant or lactating females.","ALL","18 Years",{"count":55,"type":56},60,"ESTIMATED","OBSERVATIONAL","The aim of this study is to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Sohag University Hospital.",[60,61],"Metabolic Dysfunction-Associated Steatotic Liver Disease","Acute Coronary Syndromes (ACS)",[63,64,65,66,67],"Mean platelet volume","Cardiovascular risk","Platelet activation","Metabolic syndrome","Liver staetosis","NOT_YET_RECRUITING","2026-04-30",{"date":71,"type":72},"2026-05-06","ACTUAL",{"date":74,"type":56},"2026-05-05",{"date":76,"type":56},"2026-12-01",{"name":5,"class":6},1]